Insperity, Inc.'s Q2 2026 revenue was $1.69B (+1.7% year over year). Gross profit was $217.0M. Net income was $4.0M.

Guidance: Q2 2026 Revenue: $1.7 billion. Full-year 2026 Adjusted EBITDA Guidance: $185 million to $225 million. Full-year 2026 Adjusted EPS Guidance: $1.88 to $2.43. Full-year 2026 average paid WSEEs are expected to decrease 1.0–1.7%. Q3 2026 Adjusted EBITDA Guidance: $14 million to $41 million. Q3 2026 Adjusted EPS Guidance: $(0.09) to $0.41. Q3 2026 average WSEEs paid are expected to decrease 2.3% year-over-year.

Insights & Commentary

"Benefits cost per covered employee increased by 5.2% over Q2 of 2025, consistent with our expectations and first quarter results." — Insperity Q2 2026 Earnings Call

"Management has indicated the plan is positioned to deliver significant profit gains by year-end, but that outcome depends entirely on execution and whether benefits cost pressures ease." — 24/7 Wall St. analysis

"Management said its margin recovery plan is working, supported by lower operating expenses and steadier benefits costs." — Investing.com analysis

"Our benefits cost trends have been relatively stable so far this year, but we are maintaining a wider range of potential outcomes in the second half of the year relative to our historical norms due to the elevated healthcare cost trends that remain in the marketplace." — Insperity Q2 2026 Earnings Call

"Benefits costs per covered employee rose ~5% versus prior year; company implemented benefit plan and policy changes as part of margin recovery." — Insperity Q2 2026 Earnings Summary

"Our benefits costs per covered employee increased 5% over Q2 2025." — Insperity Q2 2026 Press Release

Figures from SEC EDGAR filings for the period ended 2026-06-30. Commentary from public earnings-call transcripts and coverage.